Skip to main content

University of Salford home

Centre for Applied Health Research

  • Home
    • Digital Health and Medical Imaging
    • Equity, Inequalities, and Inclusivity
    • Care Across the Lifecourse
    • Long Term Conditions
    • Mental Health and Neurodiversity
  • News
  • Collaborators and Partnerships
  • Our Facilities
  • Our Staff
  1. Home
  2. Mental Health and Neurodiversity
  3. Parenting Course for Parents of Children With Fetal Alcohol Spectrum Disorders (FASD) Versus Waitlist: A Randomised Controlled Feasibility Study of the SPECIFiC (Salford Parents and Carers’ Education Course for Improvements in FASD Outcomes in Children) Programme

Parenting Course for Parents of Children With Fetal Alcohol Spectrum Disorders (FASD) Versus Waitlist: A Randomised Controlled Feasibility Study of the SPECIFiC (Salford Parents and Carers’ Education Course for Improvements in FASD Outcomes in Children) Programme

Foetal alcohol spectrum disorder (FASD) is a neurodevelopmental disorder that affects an estimated 2-4% of children in the UK. There is a lack of services for people with FASD, their parents and carers. Several adoptive parents of children with FASD told us they were offered parenting courses that were not designed for FASD, so we decided to fill that gap by writing one. SPECIFiC is a 7-week, online, group training course for caregivers of young children with FASD – the first of its kind in the UK. Preliminary results suggest SPECIFiC was feasible, useful, and well-received by a small number of families. We are currently testing our parenting programme in a pilot trial, where it is being delivered to 120 families. We are collecting data from our participants to measure the effects of SPECIFiC on parenting stress, parenting self-efficacy, children’s behavioural difficulties, parents’ mental health symptoms, and parents’ knowledge of FASD. The project is being funded by grants from NIHR and the Oglesby Foundation worth a combined £400,000, and this pilot trial will lead into a larger randomised controlled trial. Eventually, SPECIFiC has the potential to become the main post-diagnostic treatment for families affected by FASD in the UK.

Team

Prof Penny Cook

Prof Raja Mukherjee

Prof Clare Allely

Prof Simon Skene

Dr Alan Price

Dr David Tate

Dr Jen Shields

Dr Kathy Perryman

Mr Paul Earl

Ms Anna Webster

© 2025 University of Salford